Spiorad Medical
Developer of a large-bore femoral artery closure device intended to close 12F–24F arterial access sites. The company combines clinical interventional cardiology expertise and device development, and engages in preclinical validation and clinical evaluation with external collaborators.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Large-bore femoral artery closure device (in development)
A vascular closure device under development intended to close large French (12F–24F) femoral artery access sites used in interventional procedures.
Large-bore femoral artery closure device (in development)
A vascular closure device under development intended to close large French (12F–24F) femoral artery access sites used in interventional procedures.
Services
Partnerships with clinical centers and industry partners to support preclinical testing, clinical evaluation and development activities.
Partnerships with clinical centers and industry partners to support preclinical testing, clinical evaluation and development activities.
Expertise Areas
- Vascular device development
- Preclinical validation (animal studies)
- Clinical evaluation in interventional cardiology
- Collaborative development and partnerships
Key Technologies
- Large-bore vascular closure engineering
- Catheter-based vascular access management
- Preclinical animal models for device testing
- Clinical evaluation in interventional cardiology
News & Updates
Announcement that the company was shortlisted for the MedTech Innovator 2024 Accelerator cohort.
Selected to participate in the MedTech Innovator 2024 Accelerator program.
Announcement that the company was shortlisted for the MedTech Innovator 2024 Accelerator cohort.
Selected to participate in the MedTech Innovator 2024 Accelerator program.